CME PROGRAMME ON HAEMOVIGILANCE PROGRAMME OF INDIA Organized by National Institute of Biologicals & Indian Pharmacopoeia Commission, MoHFW, Govt. of India In collaboration with National Rural Health Mission, Jammu & Kashmir on 12th June, 2014 at Leh, J & K PROGRAMME SCHEDULE S. No. Programme Speaker Time 1 Registration and Tea 2 Welcome Address/ Introductory Remarks Dr. S. Manivannan, Deputy Drugs Controller, CDSCO 11:00 am -11:10 am 3 Introductory SpeechHaemovigilance Programme of India (HvPI) Dr. Surinder Singh, Director I/c National Institute of Biologicals (NIB) 11:10 am - 11:30 am 4 Drugs & Cosmetics Rules and Reporting of Adverse Transfusion Reactions Dr. G. Selvaraj, Ex Director of Drugs Control, Tamil Nadu 5 Reporting of Serious Adverse Reactions in Transfusion through Haemo-Vigil Software Ms. Akanksha Bisht, Member Secretary- HvPI, Indian Pharmacopoeia Commission (IPC) 10:30 am -11:00 am 11:30 am - 12:00 pm 12:00 pm - 12:30 pm Moderator : Dr. Yashpal Sharma, Mission Director, National Rural Health Mission, J&K 6 Panel discussion on Haemovigilance Programme of India 7 Vote of thanks 8 Lunch Panel Members : Dr. Surinder Singh, Director I/c National Institute of Biologicals (NIB) Dr. Baljeet Singh Pathania, Director Health Services, Jammu Dr. Saleem Ur Rehman, Director Health Services, Kashmir Dr. Phunchok Wangchuk, Chief Medical Officer/ Vice Chairman, District Health Society, Leh Dr. G. Selvaraj, Ex Director of Drugs Control, Tamil Nadu Dr. S. Manivannan, Deputy Drugs Controller, CDSCO Dr. Phunchok Wangchuk, Chief Medical Officer/ Vice Chairman, District Health Society, Leh 12:30 pm - 1:30 pm 01:30 pm - 01:40 pm 01:40 pm onwards
© Copyright 2024 ExpyDoc